Location: Suzhou, China
Date:
Event description: Novotech will be attending China ADC 2025, an industry event organized by CHUJIE Bio. The summit provides a platform for leading ADC enterprises to discuss advancements in antibody-drug conjugate (ADC) technology, promote international collaboration, and accelerate the clinical translation of ADC therapies. Novotech has extensive experience in ADC drug development, with specialized expertise in clinical sample analytical testing. Our laboratory services provide bioanalytical support for ADC trials, ensuring high-quality data for clinical development. Kexue Gong, Manager, Novotech Lab, will present on: "Strategies for Bioanalytical Sample Analysis of ADC Drugs" Date: February 20, 16:20 – 16:50 Session: Sub Forum: MRCT & Submission Strategies for ADC Drugs Meet with our team to explore how Novotech’s laboratory and clinical trial expertise can support your ADC development programs. Schedule a meeting via the form on this page.